Coronary Artery Bypass and Nitrate Oral Supplementation
- Conditions
- Coronary Artery Disease
- Interventions
- Other: Sodium chlorideDietary Supplement: Sodium nitrate
- Registration Number
- NCT01348971
- Lead Sponsor
- Karolinska Institutet
- Brief Summary
The purpose of this study is to determine whether oral sodium nitrate administration prior to coronary artery bypass surgery can reduce perioperative levels of troponin T. In addition, plasma and urine surrogate markers of renal, hepatic and brain injury will be monitored.
- Detailed Description
Nitric oxide (NO) is an important mediator in the cardiovascular system and has been shown to have protective properties in ischemia-reperfusion injury. Inorganic nitrate, an oxidation product from endogenous NO production and also a constituent in green leafy vegetables, can be recycled, via nitrite, back to bioactive NO in the body. Recent research has shown beneficial effects of nitrate and nitrite in animal models of myocardial ischemia-reperfusion injury. Moreover, dietary nitrate reduces blood pressure and oxygen cost during exercise in humans.
During coronary bypass surgery the heart undergoes ischemia-reperfusion injury and troponin T is most often released from the myocardium. The aim of the present study is to investigate if preoperative inorganic nitrate, in doses easily achievable from the diet, can affect troponin T release as well as other surrogate markers of injury to the liver, kidneys and the brain. In addition, plasma and urine samples will be collected for markers of oxidative stress and inflammation (sCRP and cytokines). Patients planned for bypass surgery who give their written informed consent will, the night before surgery, get a standardized, low-nitrate meal where after they receive sodium nitrate on two occasions preoperatively; the night before and in the morning before surgery. Plasma and urine samples will be collected at various time points up to 72 hours after surgery.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
- Patients undergoing coronary artery bypass surgery
- Over 18 years of age
- Over 80 years of age
- Pregnancy
- Reoperation
- Intended heart valve or additional surgery
- Angina or troponin release above 45 nmol/L < 48 hours before surgery
- Medication with organic nitrates/nitrites < 24 hours before surgery
- Medication with glibenclamide or corticosteroids
- Significant renal, pulmonary or hepatic disease
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo Sodium chloride Preoperative oral administration of sodium chloride the night before surgery and three hours before surgery Sodium nitrate Sodium nitrate Preoperative oral administration of sodium nitrate. 700 mg the night before surgery and 700 mg three hours before surgery
- Primary Outcome Measures
Name Time Method Troponin T release over the perioperative 72-hour period. 72 hours
- Secondary Outcome Measures
Name Time Method Creatinine kinase myocardial fraction (CKMB) release over the perioperative 24-hour period 24 hours Pro Brain natriuretic peptide (proBNP) release over the perioperative 72-hour period. 72 hours Aspartate aminotransferase (AST) release over the perioperative 72-hour period. 72 hours Alaninaminotransferas (ALAT) release over the perioperative 72-hour period. 72 hours Alkaline phosphatase (ALP) release over the perioperative 72-hour period. 72 hours Bilirubin release over the perioperative 72-hour period 72 hours Troponin T release over the perioperative 24-hour period. 24 h Creatinine kinase myocardial fraction (CKMB) release over the perioperative 72-hour period 72 hours Creatinine release over the perioperative 72-hour period 72 h Cystatin C release over the perioperative 72-hour period 72
Trial Locations
- Locations (1)
Karolinska University Hospital
🇸🇪Stockholm, Sweden